Currently, scientists in the United Kingdom are testing (in a multicenter, Phase 2 clinical trial) the ability of IL-7 to produce an immune reconstitution of COVID-19′s severe patients and observing possible association with their clinical improvement [153]. Here, IL7 is linked to COVID-19.